Soriot points out that Europe now faces a double threat. On one hand, major pharmaceutical companies are investing heavily in the United States to avoid their products being heavily taxed by the Trump administration. On the other, China is already a leader in generics and has become a formidable competitor in innovative medicines.



That’s not bad if we discuss the problems and figure out solutions. However if the problems cannot be solved then it is demotivating.
What kind of audience are we?